Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

THYRO-BLOCK

POTASSIUM IODIDE

Standard Dose
130MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview THYRO-BLOCK is listed in Drugs@FDA under application 018307 (NDA).

Marketing status: Discontinued Active ingredient POTASSIUM IODIDE Form and strength TABLET;ORAL - 130MG Sponsor MEDA PHARMS Submission history Latest submission status date: 2000-09-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview THYRO-BLOCK is listed in Drugs@FDA under application 018307 (NDA). Marketing status: Discontinued Active ingredient POTASSIUM IODIDE Form and strength TABLET;ORAL - 130MG Sponsor MEDA PHARMS Submission history Latest submission status date: 2000-09-21 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.